Contribution of calcium-activated neutral protease to the degradation process of ischemic heart.
Toyo-oka
T
T
Second Department of Internal Medicine, University of Tokyo, Japan.
Morita
M
M
Shin
W S
WS
Okaimatsuo
Y
Y
Sugimoto
T
T
D000818:Animals; D002154:Calpain / Q000037:antagonists & inhibitors / Q000502:physiology*; D003327:Coronary Disease / Q000201:enzymology* / Q000378:metabolism; D004285:Dogs; D006801:Humans; D009124:Muscle Proteins / Q000378:metabolism; D009206:Myocardium / Q000201:enzymology* / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D011480:Protease Inhibitors / Q000494:pharmacology; D011817:Rabbits
D009124:Muscle Proteins; D010879:Piperazines; D011480:Protease Inhibitors; C036798:NCO 700; D002154:Calpain